Meera J. Desai - 01 Oct 2021 Form 3 Insider Report for Adamis Pharmaceuticals Corp

Role: Director
Signature: /s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 06 Oct 2021, 16:48:29 UTC
Next filing: 30 May 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney